Sanofi India Ltd.

•

sanofiindialtd.comBSE: 500674NSE: SANOFI

Market Cap₹ 7,093 Cr.

Current Price

High / Low₹ 5,114 / 3,054

Stock P/E17.2

Book Value—

Price to Book17.80

Dividend Yield3.99 %

ROCE46.2 %

ROE36.1 %

Face Value₹ 10

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Company is almost debt free
Company has a healthy return on capital (ROCE) of 59.3%
Company has a good return on equity (ROE) track record: 3 Years ROE 43.2%
Strong cash generation - operating cash flow backs reported profits (CFO/PAT 0.93x)
Company has been maintaining a healthy dividend payout of 65.1%

CONS

Receivables are growing faster than sales - a possible quality concern
Recent results are weak - TTM profit is down 57.9% versus prior year
Stock is trading at 17.8x its book value
Recurring exceptional / one-off items are inflating headline profit
Inventory has been piling up - inventory days up from 68 to 103

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	SUNPHARMA	1842.00	36.54	441957.50	0.87	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9326.00	84.64	247576.00	0.32	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4975.00	86.76	189233.01	0.76	566.00	3.28	4921.00	57.32	19.27	33.81
4.	ZYDUSLIFE	1119.50	24.74	111670.55	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
5.	CIPLA	1365.00	32.72	110272.68	0.95	785.55	-39.18	7119.28	4.13	16.00	16.73
6.	LAURUSLABS	1970.35	97.37	106460.42	0.10	362.07	123.94	2026.31	29.10	18.20	31.50
7.	DRREDDY	1161.00	30.07	96906.38	0.69	435.60	-69.10	8099.80	-5.21	13.75	10.63
8.	AUROPHARMA	1675.45	25.97	96401.69	0.24	10320.30	1152.16	91503.50	1062.96	12.76	20.54
9.	LUPIN	2096.00	17.34	95842.92	0.86	1416.98	16.01	8276.89	34.28	28.86	29.59
10.	MANKIND	2277.00	46.04	94050.37	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
11.	GLENMARK	2416.90	37.94	68210.88	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	SANOFI	3079.85	17.16	7093.09	3.99	91.30	-93.37	514.90	9.74	55.46	26.08

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
	515	491	469	732	464	524	515
	393	377	370	514	348	404	397
Operating Profit	122	114	100	219	116	120	118
OPM %	23.62%	23.13%	21.23%	29.89%	24.96%	22.84%	22.98%
	16	11	9	-20	-14	2	14
Interest	1	0	0	0	0	0	0
Depreciation	9	9	9	10	9	9	10
Profit before Tax	127	115	99	188	92	113	122
Tax %	36.37%	29.67%	29.81%	27.49%	25.95%	27.00%	25.29%
Net Profit	1,229	1,519	1,377	137	1,032	82	91
	53.37	65.95	30.26	59.31	44.81	35.69	39.64

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Dec 2004	Dec 2023	Dec 2024	TTM
	743	1,996	2,013	2,235
	511	1,509	1,523	1,662
Operating Profit	231	487	490	573
OPM %	31.14%	24.40%	24.35%	25.62%
	27	80	-21	-18
Interest	0	2	2	2
Depreciation	19	36	37	38
Profit before Tax	239	528	431	515
Tax %	34.75%	31.01%	27.28%	26.59%
Net Profit	156	365	314	378
EPS	67.71	262.13	179.70	—
Dividend Payout %	23.63%	63.71%	65.11%	—

COMPOUNDED SALES GROWTH

10 Years:: —
5 Years:: —
3 Years:: —

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: —
3 Years:: —

STOCK PRICE CAGR

10 Years:: -3%
5 Years:: -18%
3 Years:: -24%
1 Year:: -39%

RETURN ON EQUITY

10 Years:: —
5 Years:: —
3 Years:: 43%
Last Year:: 36%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Dec 2004	Dec 2023	Dec 2024
Equity Capital	23	23	23
	431	924	768
	20	14	14
Trade Payables	40	292	406
	91	3,451	3,468
Total Liabilities	606	4,703	4,679
	167	315	312
Capital Work in Progress	3	13	18
	111	664	500
	93	132	230
Cash & Bank	180	406	295
	51	3,173	3,324
Total Assets	606	4,703	4,679

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Dec 2004	Dec 2023	Dec 2024
	85	230	462
Cash from Investing	2	38	-19
Cash from Financing	-42	-878	-392
	45	-610	50

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Dec 2004	Dec 2023	Dec 2024

Shareholding Pattern

Numbers in percentages

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	60.40	60.40	60.40	60.40	60.40	60.40	60.40	60.40	60.40
	5.81	5.78	5.64	5.58	5.61	5.57	5.55	5.65	5.69
	22.60	22.62	22.71	23.02	23.06	22.28	21.30	21.12	19.87
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	11.20	11.20	11.26	11.01	10.94	11.75	12.74	12.83	14.05

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-08

Action(s) taken or orders passed

2026-09-08 - Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( SEBI (LODR) Regulations )

2026-08-31

Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

2026-08-31 - Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Receipt of Show Cause Notice from GST Authorities

2026-08-13

General Updates

2026-08-13 - Please find enclosed intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

2026-08-11

General Updates

2026-08-11 - Please find enclosed intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

2026-08-10

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-10 - Sanofi India Limited has informed the Exchange about Transcript of Investor / Analysts Call.

2026-08-06

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-06 - Sanofi India Limited has informed the Exchange about Link of Video Recording of Investor / Analysts Call

2026-08-05

Copy of Newspaper Publication

2026-08-05 - Sanofi India Limited has informed the Exchange about copies of Newspaper Publication of Financial Results for the quarter and half year ended 30th June 2026

2026-08-05

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-05 - Sanofi India Limited has informed the Exchange about Investor / Analysts Call - Presentation

2026-08-04

General Updates

2026-08-04 - Sanofi India Limited has informed the Exchange about Intimation Under Regulation 30(5) Of the Listing Regulations

News

Recent coverage and analyst commentary for SANOFI

Loading news…

🤖

AI Stock Analyst

Sanofi India Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

SUNPHARMA

1842.00

36.54

441957.50

0.87

2901.23

26.53

15299.88

10.98

19.11

28.81

DIVISLAB

9326.00

84.64

247576.00

0.32

902.00

65.50

3080.00

27.80

21.51

40.75

TORNTPHARM

4975.00

86.76

189233.01

0.76

566.00

3.28

4921.00

57.32

19.27

33.81

ZYDUSLIFE

1119.50

24.74

111670.55

0.09

990.20

-34.90

8017.00

23.97

21.39

24.54

CIPLA

1365.00

32.72

110272.68

0.95

785.55

-39.18

7119.28

4.13

16.00

16.73

LAURUSLABS

1970.35

97.37

106460.42

0.10

362.07

123.94

2026.31

29.10

18.20

31.50

DRREDDY

1161.00

30.07

96906.38

0.69

435.60

-69.10

8099.80

-5.21

13.75

10.63

AUROPHARMA

1675.45

25.97

96401.69

0.24

10320.30

1152.16

91503.50

1062.96

12.76

20.54

LUPIN

2096.00

17.34

95842.92

0.86

1416.98

16.01

8276.89

34.28

28.86

29.59

MANKIND

2277.00

46.04

94050.37

0.04

574.09

29.12

4030.59

12.89

13.24

26.30

GLENMARK

2416.90

37.94

68210.88

0.10

482.83

927.88

4018.48

31.35

20.35

20.03

SANOFI

3079.85

17.16

7093.09

3.99

91.30

-93.37

514.90

9.74

55.46

26.08

Jun 2023

Sep 2023

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Dec 2024

515

491

469

732

464

524

515

393

377

370

514

348

404

397

Operating Profit

122

114

100

219

116

120

118

OPM %

23.62%

23.13%

21.23%

29.89%

24.96%

22.84%

22.98%

-20

-14

Interest

Depreciation

Profit before Tax

127

115

188

113

122

Tax %

36.37%

29.67%

29.81%

27.49%

25.95%

27.00%

25.29%

Net Profit

1,229

1,519

1,377

137

1,032

53.37

65.95

30.26

59.31

44.81

35.69

39.64

Dec 2004

Dec 2023

Dec 2024

TTM

743

1,996

2,013

2,235

511

1,509

1,523

1,662

Operating Profit

231

487

490

573

OPM %

31.14%

24.40%

24.35%

25.62%

-21

-18

Interest

Depreciation

Profit before Tax

239

528

431

515

Tax %

34.75%

31.01%

27.28%

26.59%

Net Profit

156

365

314

378

EPS

67.71

262.13

179.70

—

Dividend Payout %

23.63%

63.71%

65.11%

—

Dec 2004

Dec 2023

Dec 2024

Equity Capital

431

924

768

Trade Payables

292

406

3,451

3,468

Total Liabilities

606

4,703

4,679

167

315

312

Capital Work in Progress

111

664

500

132

230

Cash & Bank

180

406

295

3,173

3,324

Total Assets

606

4,703

4,679

Dec 2004

Dec 2023

Dec 2024

230

462

Cash from Investing

-19

Cash from Financing

-42

-878

-392

-610

Dec 2004

Dec 2023

Dec 2024

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

60.40

5.81

5.78

5.64

5.58

5.61

5.57

5.55

5.65

5.69

22.60

22.62

22.71

23.02

23.06

22.28

21.30

21.12

19.87

Government

0.00

11.20

11.26

11.01

10.94

11.75

12.74

12.83

14.05

Sanofi India Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Sanofi India Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI